These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 17484887)

  • 21. The relationship between aquaglyceroporin expression and development of fatty liver in diet-induced obesity and ob/ob mice.
    Hirako S; Wakayama Y; Kim H; Iizuka Y; Matsumoto A; Wada N; Kimura A; Okabe M; Sakagami J; Suzuki M; Takenoya F; Shioda S
    Obes Res Clin Pract; 2016; 10(6):710-718. PubMed ID: 26747210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.
    Li Z; Yang S; Lin H; Huang J; Watkins PA; Moser AB; Desimone C; Song XY; Diehl AM
    Hepatology; 2003 Feb; 37(2):343-50. PubMed ID: 12540784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipose differentiation-related protein is a reliable lipid droplet marker in alcoholic fatty liver of rats.
    Mak KM; Ren C; Ponomarenko A; Cao Q; Lieber CS
    Alcohol Clin Exp Res; 2008 Apr; 32(4):683-9. PubMed ID: 18341646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.
    Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL
    Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PAT protein mRNA expression in primary rat hepatocytes: Effects of exposure to fatty acids.
    Grasselli E; Voci A; Pesce C; Canesi L; Fugassa E; Gallo G; Vergani L
    Int J Mol Med; 2010 Apr; 25(4):505-12. PubMed ID: 20198297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
    Yu XX; Murray SF; Watts L; Booten SL; Tokorcheck J; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E436-45. PubMed ID: 18523126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
    Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
    J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
    Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adipocyte differentiation-related protein and OXPAT in rat and human skeletal muscle: involvement in lipid accumulation and type 2 diabetes mellitus.
    Minnaard R; Schrauwen P; Schaart G; Jorgensen JA; Lenaers E; Mensink M; Hesselink MK
    J Clin Endocrinol Metab; 2009 Oct; 94(10):4077-85. PubMed ID: 19602560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.
    Sekiya M; Yahagi N; Matsuzaka T; Najima Y; Nakakuki M; Nagai R; Ishibashi S; Osuga J; Yamada N; Shimano H
    Hepatology; 2003 Dec; 38(6):1529-39. PubMed ID: 14647064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipocyte differentiation-related protein in human skeletal muscle: relationship to insulin sensitivity.
    Phillips SA; Choe CC; Ciaraldi TP; Greenberg AS; Kong AP; Baxi SC; Christiansen L; Mudaliar SR; Henry RR
    Obes Res; 2005 Aug; 13(8):1321-9. PubMed ID: 16129713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3,5-Diiodo-L-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver.
    Grasselli E; Voci A; Demori I; Canesi L; De Matteis R; Goglia F; Lanni A; Gallo G; Vergani L
    J Endocrinol; 2012 Feb; 212(2):149-58. PubMed ID: 22107956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenretinide ameliorates insulin resistance and fatty liver in obese mice.
    Koh IU; Jun HS; Choi JS; Lim JH; Kim WH; Yoon JB; Song J
    Biol Pharm Bull; 2012; 35(3):369-75. PubMed ID: 22382323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism.
    Watts LM; Manchem VP; Leedom TA; Rivard AL; McKay RA; Bao D; Neroladakis T; Monia BP; Bodenmiller DM; Cao JX; Zhang HY; Cox AL; Jacobs SJ; Michael MD; Sloop KW; Bhanot S
    Diabetes; 2005 Jun; 54(6):1846-53. PubMed ID: 15919808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perilipin discerns chronic from acute hepatocellular steatosis.
    Pawella LM; Hashani M; Eiteneuer E; Renner M; Bartenschlager R; Schirmacher P; Straub BK
    J Hepatol; 2014 Mar; 60(3):633-42. PubMed ID: 24269473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis.
    Rhee SD; Kim CH; Park JS; Jung WH; Park SB; Kim HY; Bae GH; Kim TJ; Kim KY
    Eur J Pharmacol; 2012 Sep; 691(1-3):9-18. PubMed ID: 22742899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice.
    Yahagi N; Shimano H; Hasty AH; Matsuzaka T; Ide T; Yoshikawa T; Amemiya-Kudo M; Tomita S; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Osuga J; Harada K; Gotoda T; Nagai R; Ishibashi S; Yamada N
    J Biol Chem; 2002 May; 277(22):19353-7. PubMed ID: 11923308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin-deficient mice.
    Xu J; Donepudi AC; More VR; Kulkarni SR; Li L; Guo L; Yan B; Chatterjee T; Weintraub N; Slitt AL
    Obesity (Silver Spring); 2015 Feb; 23(2):335-44. PubMed ID: 25451536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.